Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats.

A protective effect of Rho-kinase inhibitor on various organ injuries is gaining attention. Regarding liver injury, Rho-kinase inhibitor is reported to prevent carbon tetrachloride (CCl4)- or dimethylnitrosamine-induced liver fibrosis and hepatic ischemia-reperfusion injury in rats. Because Rho-kinase inhibitor not only improved liver fibrosis but also reduced serum alanine aminotransferase (ALT) level in CCl4-induced liver fibrosis, we wondered whether Rho-kinase inhibitor might exert a direct hepatocyte-protective effect. We examined this possibility in acute CCl4 intoxication in rats. Rho-kinase inhibitor, HA-1077, reduced serum alanine ALT level in rats with acute liver injury induced by CCl4 with the improvement of histological damage and the reduction of the number of apoptotic cells. In cultured rat hepatocytes in serum-free condition, HA-1077 reduced apoptosis evaluated by quantitative determination of cytoplasmic histone-associated DNA oligonucleosome fragments with the reduction of caspase-3 activity and the enhancement of Bcl-2 expression. HA-1077 stimulated phosphorylation of Akt, and wortmannin, an inhibitor of phosphatidylinositol 3-kinase (PI3-kinase)/Akt pathway, abrogated the reduction of hepatocyte apoptosis by HA-1077 in vitro. Furthermore, wortmannin abrogated the reduction of serum ALT level by HA-1077 in rats with acute liver injury induced by CCl4, suggesting that the activation of PI3-kinase/Akt pathway may be involved in the hepatocyte-protective effect by Rho-kinase inhibitor in vivo. In conclusion, Rho-kinase inhibitor prevented hepatocyte damage in acute liver injury induced by CCl4 in rats and merits consideration as a hepatocyte-protective agent in liver injury, considering its direct antiapoptotic effect on hepatocytes in vitro.

[1]  Y. Kikuchi,et al.  A Rho-kinase inhibitor, fasudil, prevents development of diabetes and nephropathy in insulin-resistant diabetic rats. , 2007, The Journal of endocrinology.

[2]  A. Nishiyama,et al.  Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury. , 2006, Journal of the American Society of Nephrology : JASN.

[3]  M. Menger,et al.  Protective effect of fasudil, a Rho‐kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury , 2006, Journal of leukocyte biology.

[4]  M. Halks-Miller,et al.  Fasudil, a Rho-Kinase Inhibitor, Attenuates Angiotensin II–Induced Abdominal Aortic Aneurysm in Apolipoprotein E–Deficient Mice by Inhibiting Apoptosis and Proteolysis , 2005, Circulation.

[5]  C. Guguen-Guillouzo,et al.  TNFα‐mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes , 2005, Hepatology.

[6]  塩谷 聡子 Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats , 2005 .

[7]  J. Liao,et al.  Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  Y. Maehara,et al.  Involvement of Rho-Kinase in Cold Ischemia-Reperfusion Injury after Liver Transplantation in Rats , 2004, Transplantation.

[9]  A. Fujimura,et al.  Partial protective effect of Y-27632, a Rho kinase inhibitor, against hepatic ischemia-reperfusion injury in rats. , 2004, European journal of pharmacology.

[10]  K. Kaibuchi,et al.  Long-Term Treatment With a Rho-Kinase Inhibitor Improves Monocrotaline-Induced Fatal Pulmonary Hypertension in Rats , 2004, Circulation research.

[11]  W. Bao,et al.  Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. , 2004, Cardiovascular research.

[12]  J. S. Sidhu,et al.  Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. , 2004, Experimental cell research.

[13]  Y. Inoue,et al.  Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[14]  S. Arii,et al.  Therapeutic significance of Y-27632, a Rho-kinase inhibitor, on the established liver fibrosis. , 2003, The Journal of surgical research.

[15]  M. Crow,et al.  Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. , 2003, Biochemical and biophysical research communications.

[16]  Anne J. Ridley,et al.  ROCKs: multifunctional kinases in cell behaviour , 2003, Nature Reviews Molecular Cell Biology.

[17]  T. Asahara,et al.  Prevention of ischemia–reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor1 , 2003, Transplantation.

[18]  Z. Radisavljevic Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells , 2003, Cancer.

[19]  Y. Yamaoka,et al.  Reduction of hepatic ischemia/reperfusion-induced injury by a specific ROCK/Rho kinase inhibitor Y-27632. , 2003, The Journal of surgical research.

[20]  S. Todo,et al.  A novel inhibitor of Rho-associated protein kinase, Y-27632, ameliorates hepatic ischemia and reperfusion injury in rats. , 2003, Surgery.

[21]  Y. Inoue,et al.  Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. , 2003, Gastroenterology.

[22]  Xianwu Li,et al.  Inhibition of Protein Geranylgeranylation and RhoA/RhoA Kinase Pathway Induces Apoptosis in Human Endothelial Cells* , 2002, The Journal of Biological Chemistry.

[23]  S. Hosoda,et al.  Anti-anginal Effect of Fasudil, a Rho-Kinase Inhibitor, in Patients With Stable Effort Angina: A Multicenter Study , 2002, Journal of cardiovascular pharmacology.

[24]  T. Nakamura,et al.  Inhibitory effect of Y-27632, a ROCK inhibitor, on progression of rat liver fibrosis in association with inactivation of hepatic stellate cells. , 2001, Journal of hepatology.

[25]  H. Nawata,et al.  A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. , 2001, Journal of hepatology.

[26]  J. Bertoglio,et al.  Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing , 2001, Nature Cell Biology.

[27]  E. Sahai,et al.  Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I , 2001, Nature Cell Biology.

[28]  M. Morimatsu,et al.  Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury , 2001, Circulation.

[29]  P. Tangkijvanich,et al.  Wound‐induced migration of rat hepatic stellate cells is modulated by endothelin‐1 through rho‐kinase‐mediated alterations in the acto‐myosin cytoskeleton , 2001, Hepatology.

[30]  H. Ikeda,et al.  Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. , 2000, Biochemical and biophysical research communications.

[31]  H. Nagumo,et al.  Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. , 2000, American journal of physiology. Cell physiology.

[32]  S. Seki,et al.  ROCK inhibitor Y-27632 attenuates stellate cell contraction and portal pressure increase induced by endothelin-1. , 1999, Biochemical and biophysical research communications.

[33]  K. Hornbrook,et al.  Serum and liver concentrations of tumor necrosis factor α and interleukin-1β following administration of carbon tetrachloride to male rats , 1998 .

[34]  Y. Ikawa,et al.  Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. , 1998, The American journal of pathology.

[35]  Jason C. Mills,et al.  Apoptotic Membrane Blebbing Is Regulated by Myosin Light Chain Phosphorylation , 1998, The Journal of cell biology.

[36]  K. Hornbrook,et al.  Serum and liver concentrations of tumor necrosis factor alpha and interleukin-1beta following administration of carbon tetrachloride to male rats. , 1998, Toxicology letters.

[37]  K. Fujisawa,et al.  p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.

[38]  David R. Kaplan,et al.  Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.

[39]  X. Q. Chen,et al.  The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton , 1996, Molecular and cellular biology.

[40]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[41]  K. Takakura,et al.  Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. , 1992, Journal of neurosurgery.

[42]  I. Sipes,et al.  Reactive oxygen species in the progression of CCl4-induced liver injury. , 1991, Advances in experimental medicine and biology.

[43]  K. Fujiwara,et al.  Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats , 1989, The Journal of pathology.

[44]  T. Nakamura,et al.  Increased survival of rat hepatocytes in serum-free medium by inhibition of a trypsin-like protease associated with their plasma membranes. , 1984, Experimental cell research.

[45]  T. Nakamura,et al.  Identification of trypsin inhibitor in bovine pituitary extracts as a survival factor for adult rat hepatocytes in primary culture. , 1984, Journal of Biochemistry (Tokyo).

[46]  T. Nakamura,et al.  Role of serum in maintenance of functional hepatocytes in primary culture. , 1982, Journal of biochemistry.

[47]  P. Seglen Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. , 1973, Experimental cell research.

[48]  P. Seglen Preparation of rat liver cells. II. Effects of ions and chelators on tissue dispersion. , 1973, Experimental cell research.